XML 51 R37.htm IDEA: XBRL DOCUMENT v3.7.0.1
Segment Reporting (Tables)
 6 Months Ended
Feb. 28, 2017
Segment Reporting [Abstract]  
Reconciliation of Revenue from Segments to Consolidated
The following table reflects results of operations of the Company’s reportable segments (in millions):
 
Retail
Pharmacy
USA
 
Retail
Pharmacy
International
 
Pharmaceutical
Wholesale
 
Eliminations
 
Walgreens
Boots
Alliance, Inc.
Three Months Ended February 28, 2017
 
 
 
 
 
 
 
 
 
Sales to external customers
$
21,814

 
$
3,101

 
$
4,531

 
$
—

 
$
29,446

Intersegment sales
—

 
—

 
499

 
(499
)
 
—

Sales
$
21,814

 
$
3,101

 
$
5,030

 
$
(499
)
 
$
29,446

 
 
 
 
 
 
 
 
 
 
Adjusted Operating Income
$
1,552

 
$
242

 
$
226

 
$
(4
)
 
$
2,016

Three Months Ended February 29, 2016
 

 
 

 
 

 
 

 
 

Sales to external customers
$
21,500

 
$
3,627

 
$
5,057

 
$
—

 
$
30,184

Intersegment sales
—

 
1

 
570

 
(571
)
 
—

Sales
$
21,500

 
$
3,628

 
$
5,627

 
$
(571
)
 
$
30,184

 
 
 
 
 
 
 
 
 
 
Adjusted Operating Income
$
1,632

 
$
335

 
$
155

 
$
(2
)
 
$
2,120

 
Retail
Pharmacy
USA
 
Retail
Pharmacy
International
 
Pharmaceutical
Wholesale
 
Eliminations
 
Walgreens
Boots
Alliance, Inc.
Six Months Ended February 28, 2017
 
 
 
 
 
 
 
 
 
Sales to external customers
$
42,473

 
$
6,063

 
$
9,411

 
$
—

 
$
57,947

Intersegment sales
—

 
—

 
1,036

 
(1,036
)
 
—

Sales
$
42,473

 
$
6,063

 
$
10,447

 
$
(1,036
)
 
$
57,947

 
 
 
 
 
 
 
 
 
 
Adjusted Operating Income
$
2,841

 
$
455

 
$
450

 
$
(4
)
 
$
3,742

Six Months Ended February 29, 2016
 

 
 

 
 

 
 

 
 

Sales to external customers
$
41,870

 
$
7,086

 
$
10,261

 
$
—

 
$
59,217

Intersegment sales
—

 
1

 
1,162

 
(1,163
)
 
—

Sales
$
41,870

 
$
7,087

 
$
11,423

 
$
(1,163
)
 
$
59,217

 
 
 
 
 
 
 
 
 
 
Adjusted Operating Income
$
2,875

 
$
650

 
$
321

 
$
(7
)
 
$
3,839
Reconciliation of Operating Income (Loss) from Segments to Consolidated
The following table reconciles adjusted operating income to operating income (in millions):
 
Retail
Pharmacy
USA
 
Retail
Pharmacy
International
 
Pharmaceutical
Wholesale
 
Eliminations
 
Walgreens
Boots
Alliance, Inc.
Three Months Ended February 28, 2017
 
 
 
 
 
 
 
 
 
Adjusted Operating Income
$
1,552

 
$
242

 
$
226

 
$
(4
)
 
$
2,016

Cost transformation
 

 
 

 
 

 
 

 
(340
)
Acquisition-related amortization
 

 
 

 
 

 
 

 
(82
)
LIFO provision
 

 
 

 
 

 
 

 
(49
)
Adjustments to equity earnings in AmerisourceBergen
 

 
 

 
 

 
 

 
(37
)
Acquisition-related costs
 

 
 

 
 

 
 

 
(29
)
Operating Income
 

 
 

 
 

 
 

 
$
1,479

Three Months Ended February 29, 2016
 

 
 

 
 

 
 

 
 

Adjusted Operating Income
$
1,632

 
$
335

 
$
155

 
$
(2
)
 
$
2,120

Cost transformation
 

 
 

 
 

 
 

 
(28
)
Acquisition-related amortization
 

 
 

 
 

 
 

 
(101
)
LIFO provision
 

 
 

 
 

 
 

 
(68
)
Acquisition-related costs
 
 
 
 
 
 
 
 
(33
)
Asset impairment
 

 
 

 
 

 
 

 
(30
)
Operating Income
 

 
 

 
 

 
 

 
$
1,860

 
Retail
Pharmacy
USA
 
Retail
Pharmacy
International
 
Pharmaceutical
Wholesale
 
Eliminations
 
Walgreens
Boots
Alliance, Inc.
Six Months Ended February 28, 2017
 
 
 
 
 
 
 
 
 
Adjusted Operating Income
$
2,841

 
$
455

 
$
450

 
$
(4
)
 
$
3,742

Cost transformation
 

 
 

 
 

 
 

 
(421
)
Acquisition-related amortization
 

 
 

 
 

 
 

 
(164
)
LIFO provision
 

 
 

 
 

 
 

 
(107
)
Adjustments to equity earnings in AmerisourceBergen
 

 
 

 
 

 
 

 
(78
)
Acquisition-related costs
 

 
 

 
 

 
 

 
(46
)
Operating Income
 

 
 

 
 

 
 

 
$
2,926

Six Months Ended February 29, 2016
 

 
 

 
 

 
 

 
 

Adjusted Operating Income
$
2,875

 
$
650

 
$
321

 
$
(7
)
 
$
3,839

Cost transformation
 

 
 

 
 

 
 

 
(118
)
Acquisition-related amortization
 

 
 

 
 

 
 

 
(182
)
LIFO provision
 

 
 

 
 

 
 

 
(114
)
Acquisition-related costs
 
 
 
 
 
 
 
 
(67
)
Asset impairment
 

 
 

 
 

 
 

 
(30
)
Operating Income
 

 
 

 
 

 
 

 
$
3,328